Holen Sie sich die Stockscreener-App
1.36
0.73%
-0.01
Handel nachbörslich:
1.35
-0.01
-0.74%
Schlusskurs vom Vortag:
$1.37
Offen:
$1.37
24-Stunden-Volumen:
2.36M
Relative Volume:
0.84
Marktkapitalisierung:
$1.04B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-7.1579
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
+7.09%
1M Leistung:
+0.00%
6M Leistung:
-1.45%
1J Leistung:
-8.11%
1-Tages-Spanne:
$1.34
$1.37
1-Wochen-Bereich:
$1.24
$1.375
52-Wochen-Spanne:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Vergleichen Sie OPK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.36 | 1.05B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | JP Morgan | Neutral |
| 2025-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
Why OPKO Health Inc. stock is considered a top pick2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - ulpravda.ru
Is OPKO Health Inc. stock attractive for income investorsQuarterly Portfolio Review & Fast Exit/Entry Strategy Plans - ulpravda.ru
Is OPKO Health Inc. stock supported by innovation pipelineJuly 2025 Recap & Consistent Profit Trade Alerts - ulpravda.ru
Setup Watch: Why OPKO Health Inc. stock appeals to analystsTrade Risk Assessment & Weekly High Return Forecasts - ulpravda.ru
Does OPKO Health Inc. stock trade at a discount to peersJuly 2025 PreEarnings & Smart Money Movement Alerts - ulpravda.ru
How OPKO Health Inc. (XCY) stock trades after earningsEarnings Forecast Updates & Low Entry Cost Investments - ulpravda.ru
OPKO Health, Inc. (NASDAQ:OPK) insiders have recently purchased stock and their bets paid off last week as company hit US$1.0b market cap - simplywall.st
Clinical Laboratory Services Market is expected to reach US$ - openPR.com
Why OPKO Health Inc. stock is rated strong buyPrice Gap Trading Strategies & Free Phenomenal Capital Appreciation - bollywoodhelpline.com
What risks investors should watch in OPKO Health Inc. stockSector Rotation Strategies & Big Gains Small Capital - ulpravda.ru
OPKO Health bets on RAYALDEE and pipeline progress for 2026 growth - MSN
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - markets.businessinsider.com
OPKO Health, Inc. to Participate in 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth - TradingView — Track All Markets
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
Patterns Watch: Is OPKO Health Inc stock a bargain at current levelsJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - moha.gov.vn
OPKO Health (NASDAQ:OPK) Stock Crosses Below 50 Day Moving AverageHere's Why - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Receives Average Rating of "Hold" from Analysts - MarketBeat
OPKO Health (NASDAQ:OPK) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Aug Breakouts: What risks investors should watch in OPKO Health Inc. stockWeekly Market Summary & Weekly Return Optimization Alerts - Улправда
Why OPKO Health Inc. stock remains a top recommendationJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - Улправда
Panic Selling: Is OPKO Health Inc. stock undervalued vs historical averages2025 Investor Takeaways & Precise Trade Entry Recommendations - ulpravda.ru
Is OPKO Health Inc. stock vulnerable to regulatory risksMarket Risk Summary & Reliable Entry Point Alerts - Улправда
Is OPKO Health Inc. stock oversold or undervaluedWeekly Investment Report & Low Drawdown Trading Strategies - ulpravda.ru
Is OPKO Health Inc. stock undervalued vs historical averagesInsider Selling & High Conviction Investment Ideas - Улправда
Is OPKO Health Inc. stock positioned for long term growthWeekly Stock Analysis & Safe Entry Trade Reports - Улправда
Can OPKO Health Inc. stock withstand economic slowdownEarnings Trend Report & Consistent Profit Alerts - DonanımHaber
Why OPKO Health Inc. stock is trending among retail tradersDip Buying & Short-Term High Return Ideas - Улправда
OPKO Health Earnings Notes - Trefis
Market Recap: Is OPKO Health Inc. stock positioned for long term growthEarnings Recap Report & Risk Managed Investment Strategies - Улправда
OPKO Health (NASDAQ:OPK) Stock Rating Lowered by Wall Street Zen - MarketBeat
Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - MSN
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - sharewise.com
Here's why you should retain OPKO Health stock in your portfolio now - MSN
Shorts Report: Why analysts upgrade OPKO Health Inc stockEarnings Growth Summary & Stock Portfolio Risk Management - BỘ NỘI VỤ
OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Brokerages - MarketBeat
What analysts say about OPKO Health Inc stockBlue Chip Stock Analysis & Learn From the Strategies of Institutions - earlytimes.in
How OPKO Health Inc. (XCY) stock valuation compares with sectorWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Why pension funds invest in OPKO Health Inc. (XCY) stockEarnings Summary Report & Weekly Stock Performance Updates - Newser
How buyback programs support OPKO Health Inc. (XCY) stockQuarterly Trade Report & High Win Rate Trade Tips - Newser
Geode Capital Management LLC Increases Stake in OPKO Health, Inc. $OPK - MarketBeat
Is OPKO Health Inc. (XCY) stock suitable for passive index fundsJuly 2025 Sentiment & Smart Money Movement Alerts - Newser
What sentiment indicators say about OPKO Health Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
Aug Shorts: Is OPKO Health Inc. stock undervalued vs historical averages2025 Valuation Update & Fast Gaining Stock Reports - moha.gov.vn
Published on: 2025-11-28 01:47:51 - BỘ NỘI VỤ
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - 富途牛牛
Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld MedTech
XCY.DE Interactive Stock Chart | Opko Health, Inc. Stock - Yahoo Finance
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):